Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CVD Equipment Corporation, a leading provider of custom chemical vapor deposition systems, today announced record Revenue, Income and Backlog.

Abstract:
CVD Equipment Corporation, a leading provider of custom chemical vapor deposition systems, today announced record Revenue, Income and Backlog.

CVD Equipment Corporation, a leading provider of custom chemical vapor deposition systems, today announced record Revenue, Income and Backlog.

Ronkonkoma, NY | Posted on August 10th, 2011

Revenue for the three and six months ended June 30, 2011 was $7,508,000 and $13,713,000 respectively, an increase of 122.1% and 93.1% over the $3,381,000 and $7,103,000 revenue achieved during the three and six months ended June 30, 2010.

Income from operations for the three and six months ended June 30, 2011 was $1,202,000 and $2,079,000 as compared to income of $126,000 and $73,000 respectively for the three and six months ended June 30, 2010.

Net Income of $778,000 for the three months ended June 30, 2011 resulted in earnings of $0.15 per share, basic and $0.14 per share diluted as compared with net income of $104,000 or $0.02 per share, basic and diluted for the three months ended June 30, 2010. Net income of $1,466,000 for the six months ended June 30, 2011 resulted in earnings of $0.29 per share, basic and $0.28 per share diluted compared to a net loss of ($30,000) or ($0.00) per share basic and diluted for the six months ended June 30, 2010.

Backlog as of June 30, 2011 was $22,208,000. This record backlog is an increase of 376.2% from the backlog of $4,664,000, reported for June 30, 2010. In addition, the backlog has increased 123.3% from the backlog total of $9,944,000 that we reported for December 31, 2010. During the six months ended June 30, 2011, we received approximately $24,700,000 in new orders. Timing for completion of the backlog varies depending on the product mix and can be as long as two years. Order backlog usually is a reasonable management tool to indicate future revenues and profits, however it does not provide an assurance of future achievement of revenues or profits as order cancellations or delays are possible. Backlog from quarter to quarter can vary based on the timing of order placements and shipments.

During the three month period ended June 30, 2011 we raised approximately $10,000,000 from the successful public offering of common stock. This capital will be used to further expand our operations to support the increased order levels and to explore additional growth opportunities.

Additionally, on August 5, 2011, we entered into a $7.0 million revolving credit line with HSBC Bank, USA at better terms than our previous $5 million line of credit with Capital One, N.A. which expired on August 1, 2011.

Leonard Rosenbaum, President and Chief Executive Officer stated, "During the 1st and 2nd quarter we continued to convert into increased revenue and profits the higher backlog of orders we started receiving during the second half of 2010 and our backlog has continued to increase during both Q1 and Q2 in 2011 to record levels. In addition, a new order in Q2 included a new endeavor for a custom CVD production solution for a medical application. We continue seeing high quotation and order levels for the First Nano/CVD Division and thru our Application Laboratory, we are also continuing to find new opportunities for custom chemical vapor deposition solutions as well as their usage in manufacturing of Graphene films, Silicon Nanowires and a range of nano materials that address solar, energy generation and energy storage markets".

CVD Equipment Corporation
Comparative Operating Results for the

Three Months Ended

Six Months Ended

6/30/2011 6/30/2010

6/30/2011

6/30/2010
Revenue $ 7,508,000 $ 3,381,000 $ 13,713,000 $ 7,103,000
Cost of revenue $ 4,635,000 $ 2,158,000 8,557,000 4,774,000
Gross profit $ 2,873,000 $ 1,223,000 5,157,000 2,329,000

Operating expenses


$

1,671,000

$

1,097,000

$

3,078,000

$

2,257,000

Net income (loss) $ 778,000 ($126,000 ) 2,074,000 (30,000 )

Net income (loss) per
common share

Basic $ 0.15 $ 0.02 $ 0.29 ($0.00 )
Diluted $ 0.14 $ 0.02 $ 0.28 ($0.00 )

Weighted average
shares of

common stock
outstanding

Basic 5,211,190 4,778,325 5,019,562 4,776,950
Diluted 5,467,704 4,813,007 5,264,530 4,817,616

####

About CVD Equipment Corporation
CVD Equipment Corporation (NASDAQ: CVV) is a designer and manufacturer of custom and standard state-of-the-art equipment used in the development, design and manufacture of advanced electronic components, materials and coatings for research and industrial applications. CVD offers a broad range of chemical vapor deposition, gas control, and other equipment that is used by customers to research, design and manufacture semiconductors, solar cells, graphene, carbon nanotubes, nanowires, LEDs, MEMS, smart glass coatings, battery and/or ultra capacitor materials, medical coatings, industrial coatings and equipment for surface mounting of components onto printed circuit boards.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release by CVD Equipment Corporation (CVD), as well as information included in oral or other written statements made or to be made by CVD, contains statements that are forward-looking. All statements other than statements of historical fact are hereby identified as "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward looking information involves a number of known and unknown risks and uncertainties that could cause actual results to differ materially from those discussed or anticipated by management. Potential risks and uncertainties include, among other factors, industry specific and general business conditions, competitive market conditions, success of CVD's growth and sales strategies, possible customer changes in delivery schedules, cancellation of orders, delays in product shipments, delays in obtaining parts from suppliers, failure to satisfy customer acceptance requirements and other risk factors described in CVD’s SEC filings. All forward-looking statements are based on management's estimates, projections and assumptions as of the date hereof and CVD assumes no obligation to update this press release.

For more information, please click here

Contacts:
CVD Equipment Corporation
Karen Hamberg, (631) 981-7081
Investor Relations
Fax: (631) 981-7095

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Chip Technology

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

Progress made in developing nanoscale electronics: New research directs charges through single molecules April 21st, 2014

'Exotic' material is like a switch when super thin April 18th, 2014

Scientists open door to better solar cells, superconductors and hard-drives: Research enhances understanding of materials interfaces April 14th, 2014

Announcements

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Tools

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014

Financial Reports

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014

Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014

Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE